{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:34:19Z","timestamp":1792708459188,"version":"4.5.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Antigen binding in monoclonal antibodies (mAbs) is traditionally associated with target recognition, but emerging evidence suggests it may also modulate antibody conformation and effector functions. Understanding how antigen engagement impacts the structural organization of therapeutic antibodies and their interaction with immune receptors is essential for optimizing antibody-based therapies. In this study, we investigated,\n                      <jats:italic>via<\/jats:italic>\n                      computational approaches, how antigen engagement alters the structural organization of therapeutic IgG1s and influences their ability to interact with Fc\u03b3RIIIa.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Accelerated molecular dynamics simulations were performed to investigate the structural and dynamic consequences of antigen binding in two therapeutic mAbs, adalimumab and avelumab. These antibodies were analyzed in different glycosylation states to capture the influence of post translational modifications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:bold>T<\/jats:bold>\n                      he results revealed consistent long-range dynamic correlations between antigen-binding regions and distant domains within the Fc, suggesting an allosteric communication network involving the entire antibody structure and mediated by the antigen binding. Antigen engagement was found to increase the exposure of Fc residues critical for immune receptor recognition, an effect modulated by glycosylation and light chain isotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings suggest that antigen engagement initiates a cascade of coordinated motions that reshape the mAb architecture and regulate its interaction with the immune receptors, offering new insights for the design of functionally optimized therapeutic antibodies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1680199","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:26:51Z","timestamp":1767875211000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Antigen binding triggers long-range conformational changes in monoclonal antibodies"],"prefix":"10.3389","volume":"16","author":[{"given":"Davide","family":"Bianchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Saporiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf","family":"Palinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ben Mariem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivano","family":"Eberini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Centola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"B1","first-page":"55","article-title":"Antibody structure and function: The basis for engineering therapeutics","volume-title":"Antibodies","author":"Chiu","year":"2019"},{"key":"B2","unstructured":"Barrett\n              JE\n            \n            \n              Page\n              CP\n            \n            \n              Michel\n              MC\n            \n          \n          10.1007\/978-3-030-35362-9\n          Cham\n          Springer International Publishing\n          Concepts and Principles of Pharmacology\n          260\n          2019"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00302","article-title":"The structural basis of antibody-antigen recognition","volume":"4","author":"Sela-Culang","year":"2013","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2016.1158370","article-title":"Length-independent structural similarities enrich the antibody CDR canonical class model","volume":"8","author":"Nowak","year":"2016","journal-title":"MAbs"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2019.01.42","article-title":"NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives","volume":"7","author":"Lo Nigro","year":"2019","journal-title":"Ann Transl Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12332","article-title":"Fc receptor inside-out signaling and possible impact on antibody therapy","volume":"268","author":"Brandsma","year":"2015","journal-title":"Immunol Rev"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-005-0353-5","article-title":"Fc receptors and their role in immune regulation and autoimmunity","volume":"25","author":"Takai","year":"2005","journal-title":"J Clin Immunol"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-019-0345-9","article-title":"Boosting therapeutic potency of antibodies by taming Fc domain functions","volume-title":"Exp Mol Med","author":"Kang","year":"2019"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1108455108\/-\/DCSupplemental","article-title":"Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc\u03b3RIII and antibodies lacking core fucose","volume":"108","author":"Ferrara","year":"2011","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B12","volume-title":"Glycosylation of recombinant antibody therapeutics. Biotechnology progress","author":"Jefferis","year":"2005"},{"key":"B13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1073\/pnas.63.1.78","article-title":"The covalent structure of an entire \u03b3G immunoglobulin molecule","volume":"63","author":"Edelman","year":"1969","journal-title":"Proc Natl Acad Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1021\/cb300130k","article-title":"Revisiting the role of glycosylation in the structure of human igG fc","volume":"7","author":"Borrok","year":"2012","journal-title":"ACS Chem Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2015.06.015","article-title":"The structural role of antibody N-glycosylation in receptor interactions","volume":"23","author":"Subedi","year":"2015","journal-title":"Structure"},{"key":"B16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s42003-023-04622-7","article-title":"Effect of Fc core fucosylation and light chain isotype on IgG1 flexibility","volume":"6","author":"Saporiti","year":"2023","journal-title":"Commun Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)01250-0","article-title":"Structural analysis of human igG-fc glycoforms reveals a correlation between glycosylation and structural integrity","volume":"325","author":"Krapp","year":"2003","journal-title":"J Mol Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jps.24444","article-title":"Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and fc-fusion proteins","volume":"104","author":"Liu","year":"2015","journal-title":"J Pharm Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1347871","article-title":"Benchmarking glycoform-resolved affinity separation \u2013 mass spectrometry assays for studying Fc\u03b3RIIIa binding","volume":"15","author":"Gst\u00f6ttner","year":"2024","journal-title":"Front Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2004.01.007","article-title":"Fucose depletion from human igG1 oligosaccharide enhances binding enthalpy and association rate between igG1 and fc\u03b3RIIIa","volume":"336","author":"Okazaki","year":"2004","journal-title":"J Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2007.02.005","article-title":"Enhanced binding affinity for Fc\u03b3RIIIa of fucose-negative antibody is sufficient to induce maximal antibody-dependent cellular cytotoxicity","volume":"44","author":"Masuda","year":"2007","journal-title":"Mol Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2619","article-title":"Nonfucosylated Therapeutic IgG1 Antibody Can Evade the Inhibitory Effect of Serum Immunoglobulin G on Antibody-Dependent Cellular Cytotoxicity through its High Binding to Fc\u03b3RIIIa","volume":"12","author":"Iida","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human igG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J Biol Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202069200","article-title":"Lack of fucose on human igG1 N-linked oligosaccharide improves binding to human fc\u03b3RIII and antibody-dependent cellular toxicity","volume":"277","author":"Shields","year":"2002","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.11.004","article-title":"The immunoglobulin constant region contributes to affinity and specificity","volume":"29","author":"Torres","year":"2008","journal-title":"Trends Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbr.2025.100034","article-title":"Structural determinants of IgG1-Fc\u03b3RIIIa interaction: A comprehensive computational study","volume":"2","author":"Bianchi","year":"2025","journal-title":"Comput Struct Biotechnol Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.23447","article-title":"Mechanisms for cytotoxic effects of anti\u2013tumor necrosis factor agents on transmembrane tumor necrosis factor \u03b1\u2013expressing cells: Comparison among infliximab, etanercept, and adalimumab","volume":"58","author":"Mitoma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mco2.70111","article-title":"Avelumab mediates antibody-dependent cellular cytotoxicity against monocyte-derived dendritic cells through natural killer cells","volume":"6","author":"Sauerer","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"B29","first-page":"910","volume-title":"Molecular operating environment (MOE)","year":"2022"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1061692","article-title":"Crystal structure of a neutralizing human igG against HIV-1: A template for vaccine design","volume":"293","author":"Saphire","year":"2001","journal-title":"Science"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2016.102","article-title":"Structural basis of anti-PD-L1 monoclonal antibody avelumab for tumor therapy","volume":"27","author":"Liu","year":"2017","journal-title":"Cell Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.491530","article-title":"Comparison of the inhibition mechanisms of adalimumab and infliximab in treating tumor necrosis factor \u03b1-associated diseases from a molecular view","volume":"288","author":"Hu","year":"2013","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2021.10.026","article-title":"IgG1 conformational behavior: elucidation of the N-glycosylation role via molecular dynamics","volume":"120","author":"Saporiti","year":"2021","journal-title":"Biophys J"},{"key":"B34","volume-title":"Amber 2021","author":"Case","year":"2021"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c7 1 and \u03c7 2 dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald\u2013an Nlog(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J Chem Phys"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J Comput Phys"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1465-4_12","article-title":"Accelerated molecular dynamics and protein conformational change: A theoretical and practical guide using a membrane embedded model neurotransmitter transporter","volume":"1215","author":"Gedeon","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1021\/ct500090q","article-title":"Improved reweighting of accelerated molecular dynamics simulations for free energy calculation","volume":"10","author":"Miao","year":"2014","journal-title":"J Chem Theory Comput"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A","article-title":"Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO)","volume":"20","author":"Weiser","year":"1999","journal-title":"J Comput Chem"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human igG1 for fc\u03b3RI, fc\u03b3RII, fc\u03b3RIII, and fcRn and design of igG1 variants with improved binding to the fc\u03b3R","volume":"276","author":"Shields","year":"2001","journal-title":"J Biol Chem"},{"key":"B42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: A toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J Comput Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1021\/jp310753z","article-title":"Investigating allostery in molecular recognition: Insights from a computational study of multiple antibody-antigen complexes","author":"Corrada","year":"2013","journal-title":"J Phys Chem B"},{"key":"B45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/19420862.2018.1522178","article-title":"Antigen binding allosterically promotes Fc receptor recognition","volume":"11","author":"Zhao","year":"2019","journal-title":"MAbs"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.518","article-title":"The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas","volume":"78","author":"Velders","year":"1998","journal-title":"Br J Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900985","article-title":"Functional attributes of antibodies, effector cells, and target cells affecting NK cell\u2013mediated antibody-dependent cellular cytotoxicity","volume":"203","author":"Temming","year":"2019","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1074\/jbc.M210665200","article-title":"The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity","volume":"278","author":"Shinkawa","year":"2003","journal-title":"J Biol Chem"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1429600","article-title":"In silico evaluation of the role of Fab glycosylation in cetuximab antibody dynamics","volume":"15","author":"Saporiti","year":"2024","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.74.12.5682","article-title":"Evidence for a long-range conformational change induced by antigen binding to IgM antibody","volume":"74","author":"Brown","year":"1977","journal-title":"Proc Natl Acad Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.7.2775","article-title":"Antigen-induced conformational changes in antibodies and their Fab fragments studied by circular polarization of fluorescence","volume":"72","author":"Schlessinger","year":"1975","journal-title":"Proc Natl Acad Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168947","article-title":"The role of fc receptors on the effectiveness of therapeutic monoclonal antibodies","volume":"22","author":"Gogesch","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.11.008","article-title":"Differences in binding and effector functions between classes of TNF antagonists","volume":"45","author":"Arora","year":"2009","journal-title":"Cytokine"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48323-w","article-title":"The Fab portion of immunoglobulin G contributes to its binding to Fc\u03b3 receptor III","volume":"9","author":"Yogo","year":"2019","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.str.2020.03.001","article-title":"Antigen-induced allosteric changes in a human igG1 fc increase low-affinity fc\u03b3 Receptor binding","volume":"28","author":"Orlandi","year":"2020","journal-title":"Structure"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1038\/ni.2939","article-title":"Type I and type II Fc receptors regulate innate and adaptive immunity","volume-title":"Nat Immunol","author":"Pincetic","year":"2014"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1307864110","article-title":"Ravetch, General mechanism for modulating immunoglobulin effector function","volume":"110","author":"Sondermann","year":"2013","journal-title":"Proc Natl Acad Sci U.S.A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1680199\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:26:55Z","timestamp":1767875215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1680199\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":57,"alternative-id":["10.3389\/fimmu.2025.1680199"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1680199","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"1680199"}}